The company was founded in 2004. The company is based on the development and transformation of biomedical soft tissue repair materials. It is a leading enterprise in innovative biomedical soft tissue materials in China, and has successfully industrialized a series of sodium hyaluronate filler products and facial implants. The company is a national high-tech enterprise engaged in the development and transformation of biomedical materials and biomedical products. The company has successfully industrialized a series of dermal fillers based on sodium hyaluronate, dermal fillers based on polylactic acid, and polydioxycyclohexanone facial implants, and is also developing biomedicines such as recombinant proteins and peptides. The company's main products currently include a series of dermal fillers based on sodium hyaluronate, dermal fillers based on polylactic acid, facial implant products, and a derived “partner” cosmetics brand matrix. The company has received many national and municipal qualifications and honors, such as the National Specialized and New “Little Giant” Enterprise, the Beijing Specialized and New “Little Giant” Enterprise, the Beijing Enterprise Technology Center, and the Beijing Intellectual Property Demonstration Unit.